Author

Vanessa R. Montoya

Observed name: Vanessa Montoya

Observed institutions: Northwestern University, Lurie Children's Hospital, University of Chicago

OpenAlex ID: A5005771182

Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression

2017 · Thomas P. Stricker, Christopher D. Brown, et al. · PLoS Genetics · 60

Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation

2015 · Vanessa Montoya, Hanli Fan, et al. · PLoS ONE · 36

1085 OPB-101: a mesothelin-specific CAR T cell therapy leveraging protein design to enhance T cell proliferation and persistence for the treatment of ovarian cancer

2024 · Rupesh H Amin, Howell Moffett, et al. · Journal for ImmunoTherapy of Cancer · 1

A Rationally Designed Transgene Drives CAR T Functional Persistence and Durable Regression of Solid Tumors

2026 · Rupesh H. Amin, Kevin G. Haworth, et al. · bioRxiv (Cold Spring Harbor Laboratory)

A Dynamically Regulated Designed IL-2 for Tumor-localized Signaling

2026 · Howell F. Moffett, Brian D. Weitzner, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Abstract 51: OPB-101: An optimized mesothelin-specific CAR T cell product expressing CD8-targeted IL-2/15 and engineered to resist T cell exhaustion

2024 · Rupesh Amin, Howell Moffett, et al. · Cancer Research

Development of a Regulated, Optimized Mesothelin Chimeric Antigen Receptor (CAR) for the Treatment of Mesothelin Positive Cancers

2023 · Jason Yokoyama, Allan Wang, et al. · Blood

Abstract 536: Elucidating the role of miRNA-31 in retinoblastoma

2014 · Vanessa Montoya, Paul J. Bryar, et al. · Cancer Research

Works count: 8

Citation count: 97

H-index: 2

I10-index: 2